Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
covid-19
5
×
life sciences
national
5
×
national blog main
national top stories
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
europe blog main
europe top stories
indiana blog main
indiana top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
boston top stories
cancer
cancer immunotherapy
clinical trials
cystic fibrosis
deals
eli lilly
fda
gilead sciences
novartis
What
bio
roundup
acquisitions
buy
ceo
daniel
days
gilead
medicines
o’day
sciences
abbvie’s
abcellera
abcellera’s
ahead
alliance
announced
antibodies
antibody
based
biggest
biofourmis
biologics
biotech
bristol
bucks
build
calls
cancer
celebrate
chance
changing
collabs
color
company’s
corner
coronavirus
covid
crispr
day
Language
unset
Current search:
covid-19
×
national
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
AbCellera’s Coronavirus “Neutralizing” Antibody Leads Enter Screening
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
